Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants - The ACEDUCT Trial

NCT05340582 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.

NCT NCT05340582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05340582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants - The ACEDUCT Trial
Lead sponsor
Mount Sinai Hospital, Canada
Phase
Phase 2
Overall status
Recruiting
Start date
December 12, 2022
Completion date
April 30, 2027
Enrollment
310 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus after premature birth